Neuroprotection by a Mitochondria-Targeted Drug in a Parkinson's Disease Model

Free Radical Biology and Medicine- Netherlands

doi 10.1016/j.freeradbiomed.2010.08.028

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

A Spirulina-Enhanced Diet Provides Neuroprotection in an Α-Synuclein Model of Parkinson's Disease

PLoS ONE
Multidisciplinary
2012English

Mitochondria and Neuroprotection in Stroke: Cationic Arginine-Rich Peptides (CARPs) as a Novel Class of Mitochondria-Targeted Neuroprotective Therapeutics

Neurobiology of Disease
Neurology
2019English

Amyloid-Beta Neuroprotection Mediated by a Targeted Antioxidant

Scientific Reports
Multidisciplinary
2014English

Limb Use and Complex Ultrasonic Vocalization in a Rat Model of Parkinson's Disease: Deficit-Targeted Training

Parkinsonism and Related Disorders
GerontologyGeriatricsNeurology
2008English

Role of the Prolyl Isomerase Pin1 in the Pathogenesis of Parkinson's Disease and Neuroprotection by Novel Targeted Compounds in Pre-Clinical Animal Models of the Disease

English

Ex Vivogene Delivery of GDNF Using Primary Astrocytes Transduced With a Lentiviral Vector Provides Neuroprotection in a Rat Model of Parkinson's Disease

European Journal of Neuroscience
Neuroscience
2005English

Mitochondria-Mediated Damage to Dopaminergic Neurons in Parkinson's Disease (Review)

International Journal of Molecular Medicine
MedicineGenetics
2017English

Recent Progress in Mitochondria-Targeted Drug and Drug-Free Agents for Cancer Therapy

Cancers
Cancer ResearchOncology
2019English

Compensatory Mechanisms of Neuroprotection by PKD Signaling Against Oxidative Damage in Experimental Models of Parkinson's Disease (PD): Relevance to PD Drug Discovery Strategies

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy